Fetal Anomalies Scan at the Time of Nuchal Translucency Study
1 other identifier
observational
600
1 country
1
Brief Summary
Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 21, 2009
CompletedFirst Posted
Study publicly available on registry
July 22, 2009
CompletedNovember 20, 2009
November 1, 2009
July 21, 2009
November 19, 2009
Conditions
Keywords
Eligibility Criteria
All pregnant women at 12-14 weeks of gestation that are coming for nuchal translucency examination and willing to participate in the study.
You may qualify if:
- pregnant women at 12-14 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sheba Medical Center
Ramat Gan, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
July 21, 2009
First Posted
July 22, 2009
Study Start
June 1, 2008
Last Updated
November 20, 2009
Record last verified: 2009-11